Nadine Jahchan

Nadine Jahchan is a seasoned expert in the field of immuno-oncology and precision medicine, currently serving as the Scientific Director for Precision Medicine Immuno-Oncology at AbbVie since March 2024. Prior to this role, Jahchan held the position of Director of Translational Medicine at Adicet Bio, Inc. from April 2023 to March 2024 and served as Director of Biomarkers and Translational Research at Pionyr Immunotherapeutics from May 2018 to May 2023. Jahchan's extensive experience includes significant positions at ORIC Pharmaceuticals, Stanford University School of Medicine, UC Berkeley, and UCLA, contributing to groundbreaking research in cancer biology and molecular mechanisms. Jahchan earned a PhD in Molecular and Cell Biology from the University of California, Berkeley, and a Bachelor of Science in Molecular, Cell, and Developmental Biology from UCLA.